Matches in SemOpenAlex for { <https://semopenalex.org/work/W33439092> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W33439092 endingPage "22" @default.
- W33439092 startingPage "519" @default.
- W33439092 abstract "Clobetasol propionate 0.05% has been the mainstay in treating vulvar lichen sclerosus (VLS) for the past ten years. The usual length of therapy is two to 12 weeks. We conducted this study to evaluate the efficacy and safety of treating severe lesions of VLS in postmenopausal women for a longer time on a regular basis using clobetasol propionate.From 1997-2000, 137 women with VLS were examined in the Colposcopy and Laser Surgery Unit of Alexandra Hospital. Patients who were premenopausal, had previous therapy, exhibited mild or moderate disease or showed VIN or invasive cancer on vulvar biopsies were excluded from the study. The remaining women were divided into two groups. The first group applied clobetasol propionate 0.05% for three months and afterwards on an as required basis, whereas the second group used the ointment for six months on a regular basis. All patients were examined at two, three, six and 12 months following treatment. Signs and symptoms before and after therapy as well as side-effects caused by the ointment were recorded.The mean age of the women was 60.2 years. Fifty-four patients were divided into two categories. In the 6-month follow-up, 59% of the 1st group and 85% of the second had complete response regarding their symptoms whereas on the 12-month follow-up, the respective numbers were 48% and 74%. Concerning the signs, 30% of the first group and 55.5% of the second showed to have complete response after six months and 26% and 41% respectively after 12 months. All differences between the two groups, except the signs after 12 months, were statistically significant. There were no side-effects from the long-term use of clobetasol propionate 0.05%.Conservative management of severe lesions of VLS in postmenopausal women using clobetasol propionate 0.05% for a long time (6 months) on a regular basis, seems to be a safe and effective therapy. Improvement is observed primarily on the symptoms and less on the signs." @default.
- W33439092 created "2016-06-24" @default.
- W33439092 creator A5008278868 @default.
- W33439092 creator A5015696401 @default.
- W33439092 creator A5025685858 @default.
- W33439092 creator A5039173459 @default.
- W33439092 creator A5071512181 @default.
- W33439092 creator A5080532268 @default.
- W33439092 creator A5083886109 @default.
- W33439092 date "2002-01-01" @default.
- W33439092 modified "2023-09-27" @default.
- W33439092 title "Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%." @default.
- W33439092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12556095" @default.
- W33439092 hasPublicationYear "2002" @default.
- W33439092 type Work @default.
- W33439092 sameAs 33439092 @default.
- W33439092 citedByCount "8" @default.
- W33439092 countsByYear W334390922013 @default.
- W33439092 countsByYear W334390922018 @default.
- W33439092 countsByYear W334390922019 @default.
- W33439092 countsByYear W334390922020 @default.
- W33439092 crossrefType "journal-article" @default.
- W33439092 hasAuthorship W33439092A5008278868 @default.
- W33439092 hasAuthorship W33439092A5015696401 @default.
- W33439092 hasAuthorship W33439092A5025685858 @default.
- W33439092 hasAuthorship W33439092A5039173459 @default.
- W33439092 hasAuthorship W33439092A5071512181 @default.
- W33439092 hasAuthorship W33439092A5080532268 @default.
- W33439092 hasAuthorship W33439092A5083886109 @default.
- W33439092 hasConcept C126322002 @default.
- W33439092 hasConcept C141071460 @default.
- W33439092 hasConcept C16005928 @default.
- W33439092 hasConcept C2776110085 @default.
- W33439092 hasConcept C2776552008 @default.
- W33439092 hasConcept C2777911890 @default.
- W33439092 hasConcept C2780564577 @default.
- W33439092 hasConcept C2781115071 @default.
- W33439092 hasConcept C71315377 @default.
- W33439092 hasConcept C71924100 @default.
- W33439092 hasConceptScore W33439092C126322002 @default.
- W33439092 hasConceptScore W33439092C141071460 @default.
- W33439092 hasConceptScore W33439092C16005928 @default.
- W33439092 hasConceptScore W33439092C2776110085 @default.
- W33439092 hasConceptScore W33439092C2776552008 @default.
- W33439092 hasConceptScore W33439092C2777911890 @default.
- W33439092 hasConceptScore W33439092C2780564577 @default.
- W33439092 hasConceptScore W33439092C2781115071 @default.
- W33439092 hasConceptScore W33439092C71315377 @default.
- W33439092 hasConceptScore W33439092C71924100 @default.
- W33439092 hasIssue "6" @default.
- W33439092 hasLocation W334390921 @default.
- W33439092 hasOpenAccess W33439092 @default.
- W33439092 hasPrimaryLocation W334390921 @default.
- W33439092 hasRelatedWork W2006342158 @default.
- W33439092 hasRelatedWork W2023524291 @default.
- W33439092 hasRelatedWork W2035926450 @default.
- W33439092 hasRelatedWork W2064207514 @default.
- W33439092 hasRelatedWork W2255635774 @default.
- W33439092 hasRelatedWork W2406447885 @default.
- W33439092 hasRelatedWork W2417030501 @default.
- W33439092 hasRelatedWork W2600083549 @default.
- W33439092 hasRelatedWork W2790468903 @default.
- W33439092 hasRelatedWork W33439092 @default.
- W33439092 hasVolume "23" @default.
- W33439092 isParatext "false" @default.
- W33439092 isRetracted "false" @default.
- W33439092 magId "33439092" @default.
- W33439092 workType "article" @default.